[Evaluation of clinical therapeutic efficacy by injecting adriamycin to the nerve in primary trigeminal neuralgia].
Sixty-eight cases suffering from primary trigeminal neuralgia were performed by injecting adriamycin to the nerve. The results show that the symptoms of trigeminal neuralgia completely disappeared in all the cases during two weeks after the operation in which 63.2% in 24 hours, 28.9% in one week and 7.9% in two weeks. the recurrence rate in three years was 10.3% and in three to five years was 15.4%. This technique has the features of low recurrence rate, steady therapeutic effect, safety and microtrauma.
Liu
J B
JB
Department of Stomatology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Wu
H J
HJ
Zhu
Z F
ZF
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D014276:Trigeminal Nerve; D014277:Trigeminal Neuralgia / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin